Add BrightSurf on Google Email

Rockefeller University Press


Metabolite common among cancers

A study found that mutations in IDH1 enzyme result in excess production of 2-HG, a metabolite common among cancers including leukemia and brain tumors. Elevated serum levels of 2-HG were detected in approximately 8% of AML patients with these mutations.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateFeb 8, 2010

Immune protein fends off exotic virus

A recent study published in the Journal of Experimental Medicine reveals that type I interferons are essential for combating Chikungunya virus infection. The unexpected finding is that fibroblasts, not immune cells, produce the virus-fighting proteins during infection.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateFeb 1, 2010

Antibodies attack immune proteins

Two studies published in Journal of Experimental Medicine reveal that patients with a rare autoimmune disease produce antibodies that bind and disarm cytokines, which fight airborne pathogens. These findings may help explain the recurring nature of these patients' yeast infections.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateFeb 1, 2010

Tumor suppressor p53 prevents cancer progression in cells with missegregated chromosomes

Researchers found that tumor suppressor p53 limits the growth of cells with incorrect numbers of chromosomes and prevents their progression toward cancer. Cells lacking p53 become aneuploid after induced missegregation, indicating that the p53 pathway normally serves to limit the propagation of cells with odd numbers of chromosomes.

SourceRockefeller University Press·JournalJournal of Cell Biology·DateFeb 1, 2010

Gender-biased heart damage

Researchers found that male hormones can help vessels around the heart regenerate, potentially explaining why men experience worse heart attacks earlier in life. Androgen replacement therapy might one day be used to treat men at risk for heart disease.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateJan 13, 2010

New ways to pressure HIV

Researchers found that unique reading frames in the HIV genome can induce immune responses, potentially leading to new ways to combat the virus. These findings may prove useful for developing more effective HIV vaccines.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateJan 11, 2010

Study shows gene positions may aid cancer diagnosis

Researchers have identified genes that switch their nuclear position in tumor cells, offering a potential new method of diagnosing cancer. The study found that eight genes consistently relocated in the nuclei of invasive breast cancer cells, allowing for accurate diagnosis with success rates similar to current clinical tests.

SourceRockefeller University Press·JournalJournal of Cell Biology·DateDec 7, 2009

Microbes help mothers protect kids from allergies

Researchers found that exposure to environmental bacteria triggers a mild inflammatory response in pregnant mice, rendering their offspring resistant to allergies. This protective mechanism could potentially prevent allergies in people by conditioning the developing immune system to tolerate microbes and allergens.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateDec 7, 2009

Aurora B answers an XIST-ential question

Researchers found that Aurora B kinase helps regulate XIST's chromatin binding by phosphorylating chromatin proteins during mitosis. This study provides insight into X chromosome silencing and may lead to a better understanding of noncoding RNAs and their role in regulating heterochromatin.

SourceRockefeller University Press·JournalJournal of Cell Biology·DateAug 24, 2009

Teasing apart T helper cells

A recent study published in the Journal of Experimental Medicine shows that IL-9 promotes a multiple sclerosis-like disease in mice. The research suggests that IL-9 production may be linked to the presence of TGF-beta rather than a specific Th cell subset, contradicting the theory of a unique 'Th9' cell subset.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateJul 27, 2009

Building memories with actin

Researchers have discovered that actin reorganization in two stages is controlled by different pathways, making it easy to encode new memories but hard to hold onto them. The Rho-ROCK pathway initiates cytoskeletal changes, while the Rac-PAK pathway solidifies them, leading to heightened synapse sensitivity and memory persistence.

SourceRockefeller University Press·JournalJournal of Cell Biology·DateJul 13, 2009

Heart saves muscle

Researchers found that a heart muscle protein, ACTC, can compensate for a lack of skeletal muscle protein, ACTA1, in mice with myopathy. Mice with this compensation survived more than three months and showed improved endurance, locomotor performance, and muscle strength.

SourceRockefeller University Press·JournalJournal of Cell Biology·DateMay 25, 2009

Immune genes adapt to parasites

A population genetics study found that parasite-driven selection has left a footprint on human DNA, particularly in immune genes. This variation correlates with parasite diversity and may contribute to the development of inflammatory bowel diseases.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateMay 25, 2009

A longer lasting tumor blocker

A study by Japanese researchers found that a molecule called M-CSF can be used to block the formation of new blood vessels in tumors, suppressing growth even after treatment is stopped. This approach differs from existing VEGF-based treatments, which have been shown to have limited long-term effects.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateApr 28, 2009

Uncooperative voltage sensors

A new JGP study advances conclusions about the essential features of the Shaker K+ channel. Researchers propose that if three of four voltage sensors are in an activated conformation, the fourth can open and close the channel by itself.

SourceRockefeller University Press·JournalJournal of General Physiology·DateApr 27, 2009

SIRT1 takes down tumors

Researchers found SIRT1 curbs cell division by speeding up the destruction of the tumor promoter c-Myc, a key finding that may aid cancer treatment. This study supports previous research suggesting SIRT1's anti-cancer effects while also identifying its role in regulating c-Myc levels.

SourceRockefeller University Press·JournalJournal of Cell Biology·DateApr 13, 2009

When cancer cells can't let go

FAK coordinates movement of migrating cancer cells by balancing the number of invadopodia that create a path for migration and the number of focal adhesions that hold the cell back. In its absence, breast cancer cells sprout extra invadopodia and form large, sticky focal adhesions.

SourceRockefeller University Press·JournalJournal of Cell Biology·DateApr 13, 2009

New link in liver cancer

A study found that removing a protective protein called STAT5 from liver cells leads to an overabundance of TGFbeta, a damage-inducing protein. This results in the activation of a cancer-promoting protein, STAT3, which can promote tumor growth.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateMar 30, 2009

Turn back, wayward axon

Researchers found that two receptors, neogenin and Unc5B, work together to guide a growing axon towards its destination. The discovery sheds light on how the axon navigates through the body and could have implications for understanding neurological disorders.

SourceRockefeller University Press·JournalJournal of Cell Biology·DateMar 9, 2009